Chemical Compound

Pravastatin 1,1,3,3-Tetramethylbutylamine

CAS Registry Number 151006-14-3
Pravastatin 1,1,3,3-Tetramethylbutylamine chemical structure
Primary Record

Pravastatin 1,1,3,3-Tetramethylbutylamine

Note: Only for scientific research or as raw materials for production.

In stock
1,752 g
Purity
99.5 %
CAS
151006-14-3

Compound Identifiers & Properties

CAS
151006-14-3
PubChem CID
46782776
SMILES
CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O.CC(C)(C)CC(C)(C)N
Canonical SMILES
CC(C)(C)CC(C)(C)N.CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)O)[C@H]21

Names & Synonyms

  • Pravastatin 1,1,3,3-Tetramethylbutylamine
  • Pravastatin TMBA Salt
  • 151006-14-3
  • RefChem:1096582
  • SCHEMBL6665649
  • UNII-T17047131H
  • RKFLVBHCVKWNON-IYNICTALSA-N
  • C23H36O7.C8H19N
  • T17047131H
  • 8220AH
  • FP27123
  • Pravastatin 1,1,3,3,-Tetramethylbutylamine
  • Pravastatin 1,1,3,3-Tetramethylbutylamine Salt
  • Pravastatin 1,1,3,3-Tetramethylbutylammonium RS
  • PRAVASTATIN 1,1,3,3-TETRAMETHYL BUTYLAMINE
  • Q27289537
  • Pravastatin 1,1,3,3-tetramethylbutylamine for assay CRS
  • PRAVASTATIN 1,1,3,3-TETRAMETHYLBUTYLAMINE [USP-RS]
  • (3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid;2,4,4-trimethylpentan-2-amine
  • 1-Naphthaleneheptanoic acid, 1,2,6,7,8,8a-hexahydro-beta,delta,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-, (1S-(1alpha(betaS*,deltaS*),2alpha,6alpha,8beta(R*),8aalpha))-, compd. with 2,4,4-trimethyl-2-pentanamine (1:1)
  • [1S-[1|A(|AS*,|AS*),2|A,6|A,8|A(R*),8a|A]]-1,2,6,7,8,8a-Hexahydro-|A,|A,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1-naphthaleneheptanoate 2,4,4-Trimethyl-2-pentanamine
  • [1S-[1a(b-S*,?S*),2a,6a,8b(R*),8a-a]]-1,2,6,7,8,8a-Hexahydro-b,?,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1-naphthaleneheptano ate
  • 1-NAPHTHALENEHEPTANOIC ACID, 1,2,6,7,8,8A-HEXAHYDRO-.BETA.,.DELTA.,6-TRIHYDROXY-2-METHYL-8-(2-METHYL-1-OXOBUTOXY)-, (1S-(1.ALPHA.(.BETA.S*,.DELTA.S*),2.ALPHA.,6.ALPHA.,8.BETA.(R*),8A.ALPHA.))-, COMPD. WITH 2,4,4-TRIMETHYL-2-PENTANAMINE (1:1)
  • 2,4,4-trimethylpentan-2-amine (3R,5R)-3,5-dihydroxy-7-((1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-(((S)-2-methylbutanoyl)oxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)heptanoate
  • 2,4,4-Trimethylpentan-2-amine (3R,5R)-3,5-dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-{[(S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoate
  • Pravastatin 1,1,3,3-Tetramethylbutylamine; 1-Naphthaleneheptanoic acid, 1,2,6,7,8,8a-hexahydro-beta,delta,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-, [1S-[1alpha(betaS*,deltaS*),2alpha,6alpha,8beta(R*),8aalpha]]-, compd. with 2,4,4-trimethyl-2-pentanamine (1:1) (9CI); 2-Pentanamine, 2,4,4-trimethyl-, [1S-[1alpha(betaS*,deltaS*),2alpha,6alpha,8beta(R*),8aalpha]]-1,2,6,7,8,8a-hexahydro-beta,delta,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1-naphthaleneheptanoate (9CI)